We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
-3.12%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$735M
AUM Growth
-$32.3M
Cap. Flow
-$7.57M
Cap. Flow %
-1.03%
Top 10 Hldgs %
32.72%
Holding
167
New
11
Increased
20
Reduced
93
Closed
7

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$14.7M
2
GSK icon
GSK
GSK
+$5.1M
3
ALB icon
Albemarle
ALB
+$4.22M
4
PGJ icon
Invesco Golden Dragon China ETF
PGJ
+$2.39M
5
XRX icon
Xerox
XRX
+$1.4M

Sector Composition

Rank Sector Weight
1 Technology 24.04%
2 Healthcare 21.31%
3 Industrials 18.46%
4 Utilities 17.61%
5 Communication Services 8.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEL icon
26
TE Connectivity
TEL
$62.6B
$10.4M 1.41%
75,734
-850
-1% -$123K
TMO icon
27
Thermo Fisher Scientific
TMO
$212B
$10.2M 1.38%
17,791
-200
-1% -$110K
BKH icon
28
Black Hills Corp
BKH
$5.42B
$10.2M 1.38%
161,883
-617
-0.4% -$42.1K
SLB icon
29
SLB Ltd
SLB
$74.6B
$9.75M 1.33%
328,901
+17,667
+6% +$506K
LNN icon
30
Lindsay Corp
LNN
$1.19B
$9.7M 1.32%
63,905
-420
-0.7% -$67.8K
MRK icon
31
Merck
MRK
$322B
$9.58M 1.3%
127,523
+48,100
+61% +$3.66M
TSM icon
32
TSMC
TSM
$2.15T
$9.58M 1.3%
85,769
-1,433
-2% -$168K
POR icon
33
Portland General Electric
POR
$5.81B
$9.41M 1.28%
200,329
-875
-0.4% -$43.1K
NJR icon
34
New Jersey Resources
NJR
$5.69B
$8.54M 1.16%
245,465
-2,000
-0.8% -$75.7K
TMP icon
35
Tompkins Financial
TMP
$1.45B
$8.49M 1.15%
104,939
+6,064
+6% +$470K
HON icon
36
Honeywell
HON
$78.4B
$7.9M 1.07%
39,489
-488
-1% -$104K
HZNP
37
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$7.6M 1.03%
69,377
-767
-1% -$79.6K
ACM icon
38
Aecom
ACM
$9.67B
$6.15M 0.84%
97,408
-1,893
-2% -$121K
CACI icon
39
CACI
CACI
$11.4B
$5.57M 0.76%
21,261
-614
-3% -$159K
AVGO icon
40
Broadcom
AVGO
$2T
$5.34M 0.73%
110,130
-1,520
-1% -$73.9K
GVA icon
41
Granite Construction
GVA
$5.45B
$5.17M 0.7%
130,693
-2,641
-2% -$104K
NXST icon
42
Nexstar Media Group
NXST
$5.87B
$4.96M 0.67%
32,650
-500
-2% -$73.7K
LITE icon
43
Lumentum
LITE
$65.6B
$4.73M 0.64%
56,643
-1,200
-2% -$101K
IDA icon
44
Idacorp
IDA
$8.21B
$4.56M 0.62%
44,143
-66
-0.1% -$6.9K
VMW
45
DELISTED
VMware, Inc
VMW
$4.45M 0.6%
29,905
-600
-2% -$91K
AZTA icon
46
Azenta
AZTA
$1.39B
$4.31M 0.59%
42,143
-300
-0.7% -$26.9K
TPC
47
Tutor Perini Cor
TPC
$4.51B
$4.12M 0.56%
317,218
+48,118
+18% +$657K
WTS icon
48
Watts Water Technologies
WTS
$11.9B
$4.03M 0.55%
23,975
-4,334
-15% -$694K
ITRI icon
49
Itron
ITRI
$4.58B
$3.92M 0.53%
51,850
+44,600
+615% +$3.82M
EWS icon
50
iShares MSCI Singapore ETF
EWS
$1.05B
$3.86M 0.53%
169,650
-7,700
-4% -$179K

Similar funds

John G. Ullman & Associates's Q3 2021 Portfolio in Review

As of Q3 2021, John G. Ullman & Associates held 167 positions worth $735M, down 4.2% from $768M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

John G. Ullman & Associates's Q3 2021 filing shows 11 new, 20 increased, 93 reduced and 7 closed positions. Its largest new stake was Ultra Clean Holdings: 68,404 shares worth $2.91M. The largest sale was Johnson & Johnson, an estimated $14.7M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

  • John G. Ullman & Associates's largest Q3 2021 buy was Ultra Clean Holdings: 68,404 shares worth $2.91M.
  • John G. Ullman & Associates added most to Itron in Q3 2021, an estimated $3.82M increase.
  • John G. Ullman & Associates's biggest Q3 2021 reduction was Johnson & Johnson, cutting an estimated $14.7M.
  • John G. Ullman & Associates fully exited Albemarle in Q3 2021, selling an estimated $4.22M.
  • John G. Ullman & Associates's ten largest holdings make up 33% of its $735M portfolio in Q3 2021.
  • John G. Ullman & Associates opened 11 new positions and closed 7 in Q3 2021.
  • John G. Ullman & Associates's portfolio value fell 4.2% quarter-over-quarter to $735M.

Based on John G. Ullman & Associates's 13F filing for Q3 2021, filed 2 Nov 2021.